4Smulian AG, Theus SA, Denko N, et al. A 55 kDa antigen of Pneumocystis carinii: analysis of the cellular immune response and characterization of the gene [J]. Mol Mierobiol, 1993, (7): 745-753.
5Smulian AG, Sullivan DW, Theus SA. Immunization with recombinant Pneurnocystis carinii p55 antigen provides partial protection against infection: characterization of epitope recognition associated with immunization [J]. Microbes Infect, 2000, (2) : 127-136.
6Ma L, Kutty G, Jia Q, et al. Characterization of variants of the gene encoding the p55 antigen in Pneumocystis from rats and mice [J]. J Med Mierohiol, 2003, (52) ..955-960.
7Empey KM, Hollifield M, Schuer K, et al. Passive immunization of neonatal mice against Pneumocystis carinii f. sp. muris enhances control of infection without stimulating inflammation [J]. Infect Immun, 2004, (72) :6211-6220.
8Theus SA, Smulian AG, Steele P, et al. Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response [J]. Vaccine, 1998, (16) :1149-1157.
9Zheng M, Ramsay AJ, Robichaux MB, et al. CD4^+ T cell-independent DNA vaccination against opportunistic infections [J]. J Clin Invest, 2005, (115) :3536-3544.
10Wells J, Haidaris CG, Wright TW, et al. Active immunization against Pneumocystis carinii with a recombinant P. carinii antigen [J]. Infect Immun, 2006, (74):2446-2448.
